Ms. Morgart underwent the multi-hour operation on December 29, 2020. Because of COVID-19 protocols, her husband could not be at the hospital when she was diagnosed or as she went into surgery; nor could he visit her during her postoperative stay. Ms. Morgart did have visitors, however: oncologists from the Morristown area. When the time came to discuss treatment, Ms. Morgart chose Jumana Chatiwala, MD, and May Abdo-Matkiwsky, DO, whom she met at Newton Medical Center at the beginning of her journey. Board-certified medical oncologists practicing in the Sparta, NJ offices of Regional Cancer Care Associates (RCCA) – one of the nation’s largest networks of oncology specialists — Dr. Chatiwala and Dr. Abdo-Matkiwsky talked with her about plans for her subsequent treatment.
“They got all of the cancer at surgery,” Ms. Morgart explains, but with a diagnosis of Stage 3 pancreatic cancer, indicating spread to the lymph nodes, preventative chemotherapy was indicated to reduce the risk of recurrence.
Getting through chemo with the help of a caring team
Ms. Morgart began her 12-cycle course of chemotherapy early in the new year – and had a rough go of it right from the start. “I got very sick after the first dose, and had a neurologic side effect after the second,” she recalls, adding that she seriously considered stopping treatment.
She says her decision – and ability – to go on and complete the full course of chemotherapy was due in large measure to the care she received from the medical oncologists, nurses, and other staff at RCCA’s Sparta office.
“They were always on top of everything going on,” Ms. Morgart says, noting that Dr. Chatiwala, who took the lead in providing her care, and nurse Lori Winters, RN, offered encouragement and compassionate support as well as carefully adjusting the chemotherapy regimen as needed and taking several steps to ease the side effects of treatment.
“Everybody in the office was phenomenal,” she says, adding that the convenience of receiving her chemotherapy infusions and related care 12 minutes from her house was a major advantage during her treatment. Ms. Morgart says, “My boss was trying to push me to go up to Yale, where he knew someone, but I said no,” because of her confidence in the care she was receiving from Dr. Chatiwala and the RCCA team.
Ms. Morgart completed her chemotherapy in July 2021. When she rang the bell in the Sparta office to mark her last treatment, Dr. Chatiwala was there to give her a hug. “She’s such a good person,” Ms. Morgart says of the physician, who has practiced in RCCA’s Sparta care center for more than six years. “She’s phenomenal. She was always there. She would come in and hold my hand,” during chemotherapy infusions, she adds of Dr. Chatiwala.
A survivor’s advice to others fighting cancer
At the start of 2022, a little more than a year after her Whipple procedure and six months after completing chemotherapy, Ms. Morgart was doing well but “not 100% back to normal” in terms of her energy level.
Looking back on her experience from the vantage point of a new year, Ms. Morgart says that an attitude and an approach helped her throughout her treatment.
“I’ve always been an ‘It is what it is, just deal with it’ person,” she explains, adding that she focused her energy on what needed to be done rather than on the “Why me?” question.
Turning to the approach that sustained her, Ms. Morgart says, “You have to be honest with yourself and all of your doctors and care team about what you’re feeling and going through.” She emphasizes, “If you’re scared, tell them that, too,” explaining that when she began to experience significant anxiety before chemotherapy sessions, she talked with Dr. Chatiwala, who prescribed a mild anti-anxiety medication that helped calm her and make the treatment more tolerable.
Dr. Chatiwala heartily echoes her patient’s advice. “There is so much that we can do today for people with cancer. That includes the major advances in treatment, such as the immunotherapies, latest chemotherapy regimens, and other cutting-edge therapies and clinical trials that RCCA makes available in community settings such as our Sparta office. But it also includes a wealth of supportive treatments and approaches to avoid or minimize side effects and to enhance patients’ quality of life during treatment. Open, honest communication between the patient and clinical team is key to all aspects of care, but it is particularly important in helping patients deal with their very understandable worries and concerns.”
The medical oncologist adds, “Brenda epitomizes the patient who is committed to being a full partner in her treatment. It is an honor for us to care for her – and for all of our patients. While people are very appreciative of what we do for them, I don’t know that they can always appreciate how much we are inspired by their courage and their resilience.”
With two grandchildren and a “terrier mutt” named Delilah who arrived just before she began chemotherapy, Ms. Morgart is looking to the future while grateful for the doctors and others who helped her through an incredibly trying year. “Rely on your care team and their support, and be totally honest with them,” she reiterates for others in the midst of their own battles with cancer.
After earning her medical degree from Maharaja Sayajirao University in India, Dr. Chatiwala completed her residency in internal medicine and fellowship in hematology-oncology at St. Joseph’s Regional Medical Center in Paterson, NJ. She is board-certified in internal medicine, hematology, and medical oncology, and is a member of the American Medical Association, American Society of Clinical Oncology, and American Society of Hematology. She has been honored as a Jersey’s Best magazine “Top Doctor” over several years.
Dr. Chatiwala is among the 90+ cancer specialists who treat patients at 25 RCCA care centers located throughout New Jersey, Connecticut, Maryland, and the Washington, DC, area. RCCA oncologists and hematologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians. They offer patients the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis—who take intravenously-administered medications.
To learn more about RCCA, call 844-928-0089 or visit RCCA.com.